Cross Research SA

CROSS Research SA provides early clinical development services, including Phase I trials in healthy volunteers and special populations, bioequivalence, pharmacokinetics, safety, cardiac safety and efficacy models, as well as studies with medical devices and nutraceuticals.[1][2][3]

The company has extensive experience in pharmacokinetics, bioequivalence, first-in-man and tolerability studies, including cardiac safety assessments and early efficacy models in healthy volunteers.[2][3]

Yes, CROSS Research is licensed for Phase I studies in healthy volunteers and special populations to assess safety, pharmacokinetics, dose regimens and regulatory requirements.[2][9]

CROSS Research SA works on drugs, medical devices and nutraceutical products as part of early clinical development programs.[1][2]

The main Phase I unit of CROSS Research is located in Arzo, Switzerland, and collaborates with the Vienna Medical University Hospital for selected hospital-based studies.[1][2][9]